Shorter individuals twice as likely to develop esophageal cancer
the ONA take:
According to a new study published in the journal Clinical Gastroenterology and Hepatology, researchers at Fred Hutchinson Cancer Research Center in Seattle, Washington, have found that taller individuals are less likely to develop Barrett's esophagus and esophageal cancer than shorter individuals.
For the study, the researchers analyzed data from 14 studies within the International Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). They found that those in the lowest quartile of height, or men under 5'7" and women under 5'2", were approximately twice as likely as those in the highest quartile of height, or men taller than 6' and women taller than 5'5", to have esophageal cancer or Barrett's esophagus.
Bases on analyses, results were consistent among various other factors, including age, body mass index, education, gastroesophageal reflux disease (GERD) symptoms, sex, and smoking. Researchers suggest that height may be able to be used as a risk factors to identify patients with a higher risk of developing Barrett's esophagus or esophageal cancer. Of note, the relationship between height and esophageal cancer observed in this study is the opposite of what has been observed in breast, colorectal, and prostate cancers.
Taller individuals are less likely to develop Barrett's esophagus and esophageal cancer.
A new study has observed that tall people are less likely to suffer from esophageal cancer as compared to short people.
The study conducted a large pooled analysis using data from 14 population-based epidemiologic studies within the International Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), including 1,000 cases of esophageal cancer and twice as many cases of Barrett's esophagus, and twice as many controls.
Sign Up for Free e-newsletters
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Cervical Cancer Outcomes Comparable With Adjuvant Chemotherapy, Chemoradiotherapy
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Mitomycin Extravasation Protocol
- Risk for Long-Term Cardiovascular Disease Increased for Endometrial Cancer Survivors
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|